İLKER KİRAZ

Dr. İLKER KİRAZ

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
İKİLKER KİRAZ
İLKER KİRAZ
VAVeli Kaan Aydin
Veli Kaan Aydin
ÖZGÜR KURTÖZGÜR KURT
ÖZGÜR KURT
MCMehmet Erdal Coşkun
Mehmet Erdal Coşkun
GLGergana Lengerova
Gergana Lengerova
Aylin KöselerAylin Köseler
Aylin Köseler
Background: Temozolomide (TMZ) resistance represents a major therapeutic challenge in glioblastoma treatment, where autophagy has emerged as a key adaptive survival mechanism. Although numerous studies have implicated autophagy in TMZ resistance, most have assessed this process at a single point, thereby overlooking its dynamic and time-dependent nature. Methods: In this study, we systematically investigated the temporal regulation of autophagy-related gene expression in two human glioblastoma cell lines with distinct MGMT methylation status and TMZ sensitivities (T98G and U87) following TMZ treatment. Cells were exposed to TMZ and harvested at defined time points (0 h, 6 h, 24 h, and 48 h). The expression levels of genes representing distinct stages of the autophagy pathway, including initiation, nucleation, elongation, selective autophagy, lysosomal function, and transcriptional regulation, were analyzed using RT-qPCR. Relative gene expression was calculated using the 2−ΔΔCT method with GAPDH as the reference gene. Results: Our results reveal a time-dependent and phase-specific transcriptional reprogramming of the autophagy machinery in response to TMZ-induced stress. Early time points were characterized by modulation of autophagy initiation and nucleation genes, whereas intermediate and late phases showed prominent regulation of genes associated with autophagosome elongation, selective autophagy, autophagic flux, and transcriptional control. Conclusions: Collectively, these findings demonstrate that autophagy in TMZ-treated glioblastoma cells is not a static response but a dynamically regulated, multi-phase program. Specifically, in TMZ-resistant T98G cells, this process matures into a sustained adaptive program with robust late-phase lysosomal integration, while in TMZ-sensitive U87 cells, the early autophagic response is transient and fails to support long-term lysosomal coordination. This temporal perspective provides new insights into the role of autophagy in TMZ tolerance and underscores the importance of time-resolved analyses when targeting autophagy to overcome chemoresistance in glioblastoma.

1 January 2025 in Pamukkale Medical Journal
Verified
Journal Article
Open access
SCSerkan Civlan
Serkan Civlan
NENevzat Doğukan Erbek
Nevzat Doğukan Erbek
İKİLKER KİRAZ
İLKER KİRAZ
EEEmrah EGEMEN
Emrah EGEMEN
EÇErdal Çoşkun
Erdal Çoşkun
Purpose: Postoperative spinal surgical site infections (SSIs) significantly impact patient morbidity, healthcare costs, and recovery. This study aimed to identify risk factors and diagnostic indicators and discuss the treatment modalities for spinal SSI through retrospective analysis. Materials and methods: Data from 36 patients with spinal SSI, operated between January 2014 and January 2018, were retrospectively evaluated. Patient-related and surgery-related risk factors, clinical presentations, laboratory findings, microbiological cultures, radiological imaging, and treatment outcomes were analysed. Results: Among 2,596 spinal surgeries, 36 SSIs (1.39%) occurred. Common risk factors included hypertension, diabetes, coronary artery disease, immunosuppression, and smoking. Early-onset infections (30 days; 27.8%) were characterised by persistent pain. CRP and neutrophil-to-lymphocyte ratio (NLR) were found to be important diagnostic markers. Culture positivity was higher in early-onset infections; Escherichia coli was the predominant pathogen. Deep infections required longer antibiotic therapy and hospital stay (p<0.05). Multidisciplinary management—including surgical debridement, irrigation, vacuum-assisted closure, and hyperbaric oxygen therapy—was essential. Despite aggressive treatment, five patients succumbed to complications. Conclusion: Meticulous risk assessment, early diagnosis using NLR and CRP, culture-guided antibiotic therapy, and individualised multidisciplinary strategies remain crucial for managing spinal SSIs effectively.

27 January 2025 in Kocatepe Tıp Dergisi
Verified
Journal Article
Open access
PDF file
İKİLKER KİRAZ
İLKER KİRAZ
NÇNazar Çiltemek
Nazar Çiltemek
AMAÇ: Tanımlayıcı ve kesitsel tipteki çalışma ile Covid-19 pandemisi sürecinde kronik bir hastalık olan osteoporozun artan vakalarını ve buna bağlı olarak osteoporozun neden olduğu vertebral kırıklarda kifoplasti/vertebroplasti sayısındaki artışı incelemektir. GEREÇ VE YÖNTEM: Bu çalışmada, 2016 ile 2022 yılları arasında vertebral kırık nedeniyle kifoplasti ve vertebroplasti uygulanan toplam 250 hastanın retrospektif analizi yapıldı. Salgın öncesi ve sonrası dönemlerde cerrahi müdahale sayıları karşılaştırıldı. Etik kurul onayı alındıktan sonra veriler toplandı ve analiz edildi. BULGULAR: İncelenen 250 hastanın %64.4'ünün kadın olduğu belirlenmiştir. Hastaların %40.8'i pandemi öncesi döneme, %59.2'si ise pandemi sonrası döneme aittir. Kifoplasti/vertebroplasti uygulanan hastaların %51.6'sında travma dışı nedenlere bağlı kırık olduğu tespit edilmiştir. Osteoporoz tanısı konulan 101 hastanın %31.6'sı pandemi öncesi döneme, %68.4'ü ise pandemi sonrası döneme aittir. Tedavi alan hastaların %48.9'u pandemi sonrası döneme aittir. SONUÇ: Bu çalışma, COVID-19 pandemisi sırasında osteoporoz tanısı alan hastalarda vertebral kırıkların arttığını ve tedaviye olan erişimin azaldığını ortaya koymaktadır. Salgın döneminde aktivite eksikliği ve tedaviye olan erişimin kısıtlanması, osteoporozla ilişkili vertebral kırıkların artmasına yol açmaktadır. Sonuç olarak, pandemi sürecinde osteoporoz tanısı alan kişi sayısının arttığı ve buna bağlı oluşan kırıklar sonucunda kifoplasti oranlarında artış olduğu görülmüştür.

10 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
İKİLKER KİRAZ
İLKER KİRAZ
GTGözde Topel
Gözde Topel
VAVeli Kaan Aydin
Veli Kaan Aydin
SCSerkan Civlan
Serkan Civlan
ÜDÜmit Akın DERE
Ümit Akın DERE
Aylin KöselerAylin Köseler
Aylin Köseler
Background: The aim of this study is to investigate the relationship between the expression levels of autophagy-related genes (SQSTM1, Beclin1, Atg5, and Atg7) in diffuse astrocytic tumors and clinicopathological parameters, including tumor grade, IDH mutation status, and survival outcomes. Materials and Methods: A total of 150 histopathologically confirmed diffuse astrocytic tumor cases were retrospectively analyzed. Clinical data were extracted from patient records. Gene expression levels were determined using qRT-PCR and evaluated by the 2−ΔCt method, where lower ΔCt values indicate higher gene expression. IDH1 R132H mutation status was evaluated by immunohistochemistry. Results: No statistically significant differences were observed in the expression levels of SQSTM1, Beclin1, Atg5, and Atg7 across WHO tumor grades (p > 0.05). However, when analyzed by IDH status, IDH-mutant tumors exhibited significantly higher gene expression levels (demonstrated by lower ΔCt values) of Beclin1 (p = 0.046) and Atg5 (p = 0.027) compared to IDH wild-type tumors. In multivariate Cox regression analysis, age and WHO tumor grades were confirmed as independent prognostic factors. Crucially, higher SQSTM1 expression independently predicted worse clinical outcomes, specifically poorer overall survival (OS) (p = 0.004) and shorter progression-free survival (PFS) (p = 0.031). Additionally, elevated Beclin1 expression was identified as an independent predictor of worse OS (p = 0.023). Conclusions: This study demonstrates that increased expression of autophagy-related genes, particularly SQSTM1 and Beclin1, serves as a robust indicator of poor prognosis and shorter survival times in diffuse astrocytic tumors. Furthermore, the elevated expression of Beclin1 and Atg5 in IDH-mutant cases highlights a complex metabolic interplay that warrants further investigation as potential therapeutic targets.

26 May 2026 in Life
Verified
Journal Article
Open access
PDF file
Aylin KöselerAylin Köseler
Aylin Köseler
AYAli Yalçın
Ali Yalçın
İKİLKER KİRAZ
İLKER KİRAZ
GLGergana Lengerova
Gergana Lengerova
MBMartina Bozhkova
Martina Bozhkova
AEAyla Sevim Erol
Ayla Sevim Erol
(1) Background: Integrated bioarchaeological approaches combining osteological and ancient DNA analyses provide powerful insights into health, disease, and population history in past societies. However, the relationship between rare skeletal variations, genetic disorders, and ancestry remains insufficiently explored within single individuals. This study aimed to investigate the combined osteological, paleopathological, and genetic characteristics of a Roman-period individual from southwestern Anatolia. (2) Methods: A multidisciplinary approach was applied to the skeletal remains of an adult male recovered from the Sekköy excavation site. Osteological analysis was conducted to assess cranial morphology, pathological lesions, and dental status. Ancient DNA was extracted from petrous bone under strict contamination control. The hemoglobin beta (HBB) gene was analyzed using Next Generation Sequencing and validated by Sanger sequencing. Y-chromosomal STR analysis was performed to determine paternal lineage. (3) Results: Osteological examination revealed a rare craniovertebral anomaly consistent with a third occipital condyle, along with porotic hyperostosis and extensive antemortem dental pathology, indicating prolonged physiological stress. Genetic analysis identified a heterozygous hemoglobin S mutation (HbAS; rs334), confirmed by both next-generation sequencing and Sanger sequencing, providing direct molecular evidence of hereditary hemoglobinopathy. Y-STR profiling assigned the individual to haplogroup R1b (predicted based on Y-STR data), indicating affiliation with Western Eurasian paternal lineages. (4) Conclusions: Despite the presence of comparable skeletal stress indicators, the integration of osteological and genetic data revealed a complex interaction between anatomical variation, chronic physiological stress, and inherited disease. The co-occurrence of a rare cranial anomaly, HbS mutation, and a defined paternal lineage represents a unique bioarchaeological case. These findings highlight the value of integrating skeletal and molecular approaches to reconstruct individual health profiles in archaeological contexts and demonstrate the methodological potential of interdisciplinary bioarcheological analysis.